Janatha Hospital And Trading Complex Profile
Key Indicators
- Authorised Capital ₹ 2.75 Cr
as on 19-12-2024
- Paid Up Capital ₹ 2.59 Cr
as on 19-12-2024
- Company Age 28 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.50 Cr
as on 19-12-2024
- Revenue %
(FY 2021)
- Profit -110.12%
(FY 2021)
- Ebitda -745.66%
(FY 2021)
- Net Worth -9.89%
(FY 2021)
- Total Assets 31.18%
(FY 2021)
About Janatha Hospital And Trading Complex
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.75 Cr and a paid-up capital of Rs 2.59 Cr.
The company has closed loans amounting to ₹3.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Puklasery Kunheedu, Muhammed Nisar, and Ali Pokkalassery serve as directors at the Company.
- CIN/LLPIN
U85110KL1995PTC009843
- Company No.
009843
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Malappuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Janatha Hospital And Trading Complex?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muhammed Nisar  | Director | 25-Jul-2016 | Current |
| Puklasery Kunheedu | Director | 15-Nov-2013 | Current |
| Ali Pokkalassery | Director | 31-Oct-2016 | Current |
Financial Performance and Corporate Structure Insights of Janatha Hospital And Trading Complex.
Janatha Hospital And Trading Complex Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 110.12% decrease in profit. The company's net worth dipped by a decrease of 9.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Janatha Hospital And Trading Complex?
In 2021, Janatha Hospital And Trading Complex had a promoter holding of 87.71% and a public holding of 12.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kerala Financial Corporation Creation Date: 27 Mar 2014 | ₹1.50 Cr | Satisfied |
Kerala Financial Corporation Creation Date: 05 May 2000 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Janatha Hospital And Trading Complex?
Unlock and access historical data on people associated with Janatha Hospital And Trading Complex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Janatha Hospital And Trading Complex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Janatha Hospital And Trading Complex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
